Susquehanna International Group’s Global X China Biotech Innovation ETF CHB Stock Holding History

Susquehanna International Group’s Portfolio CHB Stock Details CHB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,484	Closed	-$190K	–	14266
2022 Q1	$190K	Buy	+16,484	New	+$201K	﹤0.01%	11297
2021 Q3	–	Sell	-32,039	Closed	-$602K	–	13800
2021 Q2	$602K	Buy	32,039 +15,851	+98%	+$289K	﹤0.01%	9150
2021 Q1	$263K	Sell	16,188 -51,675	-76%	-$892K	﹤0.01%	10883
2020 Q4	$1.11M	Sell	67,863 -30,570	-31%	-$479K	﹤0.01%	6477
2020 Q3	$1.52M	Buy	+98,433	New	+$1.5M	﹤0.01%	5157

Other funds holding CHB

BBPWM

Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's CHB Position: Q2 2022 in Review

Susquehanna International Group sold out of Global X China Biotech Innovation ETF (CHB) in Q2 2022, closing a stake of 16,484 shares — an estimated $190K sold.

Susquehanna International Group first reported a position in CHB in Q3 2020 and held it in 5 quarters. The position peaked at $1.52M in Q3 2020. 2 funds tracked by Wall St. Rank hold CHB as of Q2 2022.

Susquehanna International Group reported no remaining Global X China Biotech Innovation ETF position as of Q2 2022 after selling out during the quarter.
Susquehanna International Group sold 16,484 Global X China Biotech Innovation ETF shares in Q2 2022, an estimated $190K.
Susquehanna International Group first reported a position in Global X China Biotech Innovation ETF in Q3 2020 and held it in 5 quarters.
Susquehanna International Group's Global X China Biotech Innovation ETF position peaked at $1.52M in Q3 2020.
2 funds tracked by Wall St. Rank held Global X China Biotech Innovation ETF as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.